224169-27-1 - Names and Identifiers
Name | GLN-1062
|
Synonyms | Memogain GLN-1062 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, 6-benzoate, (4aS,6R,8aS)-
|
CAS | 224169-27-1
|
224169-27-1 - Physico-chemical Properties
Molecular Formula | C24H25NO4
|
Molar Mass | 391.46 |
Density | 1.28±0.1 g/cm3(Predicted) |
Boling Point | 523.2±50.0 °C(Predicted) |
pKa | 7.78±0.40(Predicted) |
Storage Condition | -20℃ |
224169-27-1 - Reference
Reference Show more | 1. Maelicke A, et al. Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy. J Mol Neurosci. 2010 Jan;40(1-2):135-7. |
224169-27-1 - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 2.555 ml | 12.773 ml | 25.545 ml |
5 mM | 0.511 ml | 2.555 ml | 5.109 ml |
10 mM | 0.255 ml | 1.277 ml | 2.555 ml |
5 mM | 0.051 ml | 0.255 ml | 0.511 ml |
Last Update:2024-01-02 23:10:35
224169-27-1 - Reference Information
biological activity | memosin is a prodrug of galantamine, commonly used in Alzheimer's disease research. |
Last Update:2024-04-09 21:49:45